Fluent Perla CBD Topical
Relief Can Be a Precious Thing – Perla is an Indica-dominant hybrid produced through a cross of Cannabis sativa and Cannabis indica plants and has a ratio of 1:40 THC:CBD. As our first in-house developed strain, Perla has demonstrated a consistently robust cannabinoid profile through numerous laboratory analyses, exhibiting record-breaking quantities of CBD above 29%. The terpene content is rich with an abundance of Linalool and Pinene, providing well-balanced effects in both the body and mind. Perla is a whole-plant product that contains concentrations of CBD, THC (<.8%), and a full range of other natural components found in cannabis including terpenes, flavonoids and other cannabinoids that contribute to the medicinal properties of cannabis.
Current medical literature supports the use of CBD rich products for the treatment of pediatric and drug-resistant epilepsy (in combination with other antiepileptic medications) and chronic neuropathic pain.
CBD Content Approx: 97.6%
THC Content Approx: < 0.8%
CBD to THC: 40:1
Dosing Units: 600 mg in 30 mL (~10 mg CBD/mL; ~10 mg THC/mL)
Total Doses: 600 mg topical per 2 fl oz
Sold By: Fluent
Leave Your Review: Write A Review
Request Online Ordering For Fluent Products
Out of stock
The cannabinoids are absorbed directly into the skin for more focused therapeutic effects. Ideal for localized pain and inflammation with no psychoactive effects. Newer patients and those with a low THC tolerance can apply topicals with confidence.
Patients are recommended to initiate treatment on the evening of Day 1 with 1 – 3 topical applications of a small amount cream. After 45 min – 1 hour, patients reassess symptoms.
If symptoms have improved or subsided, no additional applications are needed and patients can apply topically as needed. Relief for patients with chronic neuropathic pain who have not responded adequately to other pain medication.
Perla® is contraindicated in patients:
• with hypersensitivity to cannabinoids (e.g., THC or CBD) or to any of the inert ingredients in Perla®;
• with a significant history of cardiovascular disease;
• with an active or previous psychotic or active mood or anxiety disorder; and
• who are pregnant, planning to become pregnant, or are breastfeeding.